DexCom Inc (DXCM)vsGE HealthCare Technologies Inc. (GEHC)
DXCM
DexCom Inc
$79.41
-5.98%
HEALTHCARE · Cap: $29.67B
GEHC
GE HealthCare Technologies Inc.
$82.38
-1.64%
HEALTHCARE · Cap: $34.25B
Smart Verdict
WallStSmart Research — data-driven comparison
GE HealthCare Technologies Inc. generates 328% more annual revenue ($21.27B vs $4.97B). DXCM leads profitability with a 20.1% profit margin vs 9.3%. DXCM appears more attractively valued with a PEG of 1.30. DXCM earns a higher WallStSmart Score of 74/100 (B).
DXCM
Strong Buy74
out of 100
Grade: B
GEHC
Buy65
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+89.9%
Fair Value
$673.64
Current Price
$79.41
$594.23 discount
Intrinsic value data unavailable for GEHC.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 39 in profit
Keeps 20 of every $100 in revenue as profit
Strong operational efficiency at 24.3%
Earnings expanding 43.6% YoY
Attractively priced relative to earnings
Areas to Watch
Premium valuation, high expectations priced in
Trading at 11.4x book value
Expensive relative to growth rate
Weak financial health signals
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : DXCM
The strongest argument for DXCM centers on Return on Equity, Profit Margin, Operating Margin. Profitability is solid with margins at 20.1% and operating margin at 24.3%. Revenue growth of 13.1% demonstrates continued momentum.
Bull Case : GEHC
The strongest argument for GEHC centers on P/E Ratio.
Bear Case : DXCM
The primary concerns for DXCM are P/E Ratio, Price/Book.
Bear Case : GEHC
The primary concerns for GEHC are PEG Ratio, Piotroski F-Score, Altman Z-Score.
Key Dynamics to Monitor
DXCM profiles as a mature stock while GEHC is a value play — different risk/reward profiles.
DXCM carries more volatility with a beta of 1.48 — expect wider price swings.
DXCM is growing revenue faster at 13.1% — sustainability is the question.
GEHC generates stronger free cash flow (793M), providing more financial flexibility.
Bottom Line
DXCM scores higher overall (74/100 vs 65/100), backed by strong 20.1% margins and 13.1% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
DexCom Inc
HEALTHCARE · MEDICAL DEVICES · USA
DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has a manufacturing facility in Mesa, Arizona.
GE HealthCare Technologies Inc.
HEALTHCARE · MEDICAL DEVICES · USA
GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?